Research and Markets: Development of New Antibiotics Hits a Road Block
DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/069cda/development_of_new) has announced the addition of GlobalData's new report "Development of New Antibiotics Hits a Road Block" to their offering. Development of New Antibiotics Hits a Road Block. The viewpoint is an essential source of information and analysis which provides the reasons for the ...

FDA Accepts for Filing Intellipharmaceutics' ANDA for Generic Lamictal(R) XR(TM)
TORONTO -- Intellipharmaceutics International Inc. today announced the U.S. Food and Drug Administration (FDA) has accepted for filing its abbreviated new drug application (ANDA) for a generic version ...

invivodata and PRO Consulting Extend Educational Webinar Series
Series Launches with Overview of Recent FDA Workshop on Clinical Outcome AssessmentsNOVEMBER 2, 2011 Pittsburgh, PA (PRWEB) November 02, 2011 -- invivodata inc. , the industry leader in patient reported outcomes (PRO) solutions and services for global clinical research, along with its scientific and regulatory consulting division, PRO Consulting , today announced that it has extended its ...